Larimar Therapeutics, Inc.

LRMR ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 17, 2021 PRIMARY DOCUMENT
4 May 17, 2021 PRIMARY DOCUMENT
8-K May 17, 2021 8-K
8-K May 11, 2021 8-K
10-Q May 10, 2021 10-Q
8-K May 10, 2021 8-K
DEF 14A Apr 14, 2021 DEF 14A
8-K/A Mar 4, 2021 8-K/A
10-K Mar 4, 2021 10-K
8-K Mar 4, 2021 8-K
SC 13G Mar 2, 2021 CHI ADVISORS LLC
SC 13G Feb 16, 2021
SC 13G Feb 16, 2021 SCHEDULE 13G
SC 13G/A Feb 16, 2021
SC 13G/A Feb 16, 2021 AMENDMENT NO. 1
SC 13G/A Feb 16, 2021 SC 13G/A
SC 13G Feb 16, 2021
SC 13G Feb 12, 2021 SCEDULE 13G
SC 13G/A Feb 11, 2021
SC 13G/A Feb 2, 2021 SC 13G/A
4 Jan 21, 2021 PRIMARY DOCUMENT
4 Jan 21, 2021 PRIMARY DOCUMENT
8-K Dec 8, 2020 8-K
8-K/A Nov 12, 2020 8-K/A
10-Q Nov 12, 2020 10-Q
← Newer Page 11 of 28 · 696 filings Older →